Myelofibrosis complicated by infection due to Candida albicans: emergence of resistance to antifungal agents during therapy.
Mori
T
T
Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
Matsumura
M
M
Kanamaru
Y
Y
Miyano
S
S
Hishikawa
T
T
Irie
S
S
Oshimi
K
K
Saikawa
T
T
Oguri
T
T
D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D002177:Candidiasis / Q000150:complications* / Q000188:drug therapy*; D004352:Drug Resistance, Microbial; D006801:Humans; D008297:Male; D008875:Middle Aged; D055728:Primary Myelofibrosis / Q000150:complications* / Q000188:drug therapy
D000935:Antifungal Agents; D000666:Amphotericin B